The Potential Drug Target PYY: Unlocking the Power of Peptide Yoke Proteins

Target Name: PYY

NCBI ID: G5697

Content of Review Report on PYY Target / Biomarker

PYY

The Potential Drug Target PYY: Unlocking the Power of Peptide Yoke Proteins

Peptide yoke proteins (PYPs) are a family of transmembrane proteins that play a crucial role in various cellular processes. Among them, Perlecan-Y (PYY) is a well-known protein that has been involved in numerous physiological functions. Its unique structure, composed of a long amino acid sequence connected to a short carboxylic acid tail, has led to a higher degree of promiscuity in its functions compared to other PYPs. This high promiscuity has piqued the interest of researchers, who are constantly searching for new drug targets. In this article, we will explore the potential drug target PYY and its role in the pharmaceutical industry.

PYY's Unique Characteristics

PYY is a 21-kDa protein that consists of a 154 amino acid residue. It has a unique feature called a \"carboxylic acid tail,\" which is a short (4 amino acid residues long) carboxylic acid stretch that connects the amino acid residues 153 and 154. This tail provides PYY with a unique way to interact with other proteins and molecules, which is crucial for its diverse functions.

PYY's Diverse Functions

PYY has been shown to play a significant role in various cellular processes, including cell adhesion, migration, and invasion. It is a critical regulator of cell-cell adhesion, as it helps maintain the integrity of the intercellular space and allows cells to stick together. Additionally, PYY has been linked to the regulation of cell migration and invasion, which are critical processes for the development and progression of diseases such as cancer.

PYY's Potential as a Drug Target

The high promiscuity of PYY, combined with its diverse functions, makes it an attractive drug target. Researchers have identified several potential PYY-targeted small molecules that have been tested in various cellular assays. One of the most promising candidates is the peptide yoke compound PYY-120, which has been shown to inhibit the migration of cancer cells.

Another promising candidate is the peptide yoke derivative PYY-236, which has been shown to inhibit the invasion of human cancer cells. Additionally, several studies have demonstrated the potential of small molecules that can modulate PYY's activity, such as the inhibitors of the enzyme PYY-ASP, which has been shown to decrease the activity of PYY in cell assays.

Conclusion

In conclusion, PYY is a protein with a unique structure and diverse functions that has piqued the interest of researchers as a potential drug target. Its promiscuity and various functions make it an attractive target for small molecules, which may lead to new treatments for various diseases. Further research is needed to fully understand the effects of PYY-targeted small molecules and to develop safe and effective drugs.

Protein Name: Peptide YY

Functions: This gut peptide inhibits exocrine pancreatic secretion, has a vasoconstrictory action and inhibitis jejunal and colonic mobility

The "PYY Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PYY comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets